Strand Displacement Amplification Market Players:
- Lucira Health Inc
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Sherlock Biosciences
- Lucigen Corporation
- Bio-Rad Laboratories Inc
- G-Biosciences
- New England Bio-Labs
- Geno Technologies Inc
- Nippon Genetics Co, Ltd.
- Proteon Pharmaceuticals
- Hopan Fine Chemicals
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of strand displacement amplification is assessed at USD 1.68 billion.
The global strand displacement amplification market size surpassed USD 1.61 billion in 2025 and is projected to witness a CAGR of over 4.5%, crossing USD 2.5 billion revenue by 2035.
North America is anticipated to command a 35% share by 2035 in the strand displacement amplification market, underpinned by rising demand for DNA-based testing and adoption of advanced gene-mutation detection technologies.
Key players in the market include Sherlock Biosciences, Lucigen Corporation, Bio-Rad Laboratories Inc., G-Biosciences, New England Bio-Labs, Geno Technologies Inc.
